![Thomas Englese](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Englese
Corporate Officer/Principal bei
TONIX PHARMACEUTICALS HOLDING CORP.
Vermögen: 9 785 $ am 31.08.2026
Profil
Thomas Joseph Englese is Director at Therakos (UK) Ltd. since 2015.
Mr. Englese is Chief Commercial Officer at Tonix Pharmaceuticals Holding Corp.
starting in 2026.
Former roles include Senior Director-Business Operations at Baxter International, Inc. from 2002 to 2008, Vice President-Customer Operations at Ikaria, Inc. from 2008 to 2015, General Manager-North America Hospital Therapies at Keenova Therapeutics Plc from 2015 to 2019, and Chief Commercial Officer at Elutia, Inc. and Tris Pharma, Inc. Education includes an MBA from The Pennsylvania State University in 2002 and an undergraduate degree from Villanova University in 1996.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 04.09.2026 | 694 ( 0.01% ) | 9 785 $ | 31.08.2026 |
Aktive Positionen von Thomas Englese
| Unternehmen | Position | Beginn |
|---|---|---|
| TONIX PHARMACEUTICALS HOLDING CORP. | Corporate Officer/Principal | 10.09.2024 |
Therakos (UK) Ltd.
 Therakos (UK) Ltd. Medical/Nursing ServicesHealth Services Develops immune cell therapies delivered through extracorporeal photopheresis | Direktor/Vorstandsmitglied | 30.10.2015 |
Ehemalige bekannte Positionen von Thomas Englese
| Unternehmen | Position | Ende |
|---|---|---|
| MALLINCKRODT PLC | Corporate Officer/Principal | 01.07.2019 |
| IKARIA, INC. | Corporate Officer/Principal | 01.03.2015 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01.01.2008 |
Tris Pharma, Inc.
 Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers therapeutics for ADHD, pain, addiction & central nervous system disorders | Corporate Officer/Principal | - |
| ELUTIA INC. | Corporate Officer/Principal | - |
Ausbildung von Thomas Englese
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
92
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Baxter International, Inc.
 Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Ikaria, Inc.
 Ikaria, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets therapeutics | Health Technology |
Keenova Therapeutics Plc
 Keenova Therapeutics Plc BiotechnologyHealth Technology Develops therapeutics for rheumatology, ophthalmology, nephrology, neurology, pulmonology, orthopedics, urology and neonatal respiratory problems | Health Technology |
The Pennsylvania State University
 The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Villanova University
 Villanova University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tonix Pharmaceuticals Holding Corp.
 Tonix Pharmaceuticals Holding Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers and develops therapeutics & diagnostics products to treat and prevent human disease and alleviate suffering | Health Technology |
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers therapeutics for ADHD, pain, addiction & central nervous system disorders | Health Technology |
Therakos (UK) Ltd.
Therakos (UK) Ltd. Medical/Nursing ServicesHealth Services Develops immune cell therapies delivered through extracorporeal photopheresis | Health Services |
Elutia, Inc.
 Elutia, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops customized tissue products | Health Technology |
